FDA approves Regeneron's antibody for rare immune disease, resolves manufacturing issues for aflibercept - Endpoints News

1. FDA approves Regeneron's antibody for rare immune disease, resolves manufacturing issues for aflibercept  Endpoints News
2. FDA approves palovarotene capsules to treat fibrodysplasia ossificans progressiva  Contemporary Pediatrics
3. US FDA approves Regeneron's ultra-rare blood disease drug  Reuters.com
4. After much trial and error, Ipsen scores FDA nod for Sohonos  FiercePharma
5. FDA Approves Ipsen’s Palovarotene for Ultra-Rare Bone Disease  BioSpace
6. View Full Coverage on Google News